Results 141 to 150 of about 28,231 (235)

Associations Between Pain Severity and Opioid Agonist Treatment Among People With Drug Injection Experience in Australia

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Pain is highly prevalent among people with opioid use disorder (OUD), yet it is often undertreated. Whether opioid agonist treatment (OAT) improves pain outcomes is unknown among this target population. This research aimed to explore associations between pain severity and current OAT status in a longitudinal cohort of people who ...
Jie Yang, Louisa Picco, Paul Dietze, Peter Higgs, Suzanne Nielsen   +4 more
wiley   +1 more source

Diagnosis and Management of Nitazene Dependence in Sydney, Australia: A Case Series

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Nitazenes are synthetic opioids with potent μ‐receptor activity. There are increasing reports of nitazene overdoses worldwide. We report on a case series of protonitazene and metonitazene dependence responding to high dose medication for the treatment of opioid dependence in both inpatient and outpatient settings.
Daniel Dutkiewicz, Hester Wilson, Peter Chisholm, Thanjira Jiranantakan, Christine Harvey, Kaniz Fatema, Mark Hardy   +6 more
wiley   +1 more source

Opioid Modulation of Major Neurotransmitter Systems: Acute, Chronic, and Withdrawal Effects

European Journal of Neuroscience, Volume 64, Issue 9, November 2026.
Opioids are widely used but also frequently misused drugs that affect multiple neurotransmitter systems, including dopaminergic, glutamatergic, GABAergic, serotonergic, and cholinergic pathways. Opioid‐induced neuroadaptations depend on the duration of drug exposure, with distinct changes also emerging following drug discontinuation.
Daniela Novakova, Eliska Pritulova, Jiri Novotny   +2 more
wiley   +1 more source

Incidence and Associated Factors for Chronic Pain After ICU Discharge: A Prospective Study

Nursing in Critical Care, Volume 31, Issue 6, November 2026.
ABSTRACT Background Survivors of critical illness are at high risk for developing chronic pain. However, evidence regarding new‐onset chronic pain in this specific population remains limited in China. Aims This study aimed to investigate the incidence of chronic pain among Chinese intensive care unit (ICU) survivors at 3 months after discharge and to ...
Jinyu Yin, Tianhao Yu, Ruirui Shen, Xiangping Chen, Yinghua Qian, Yuewen Lao, Xiaoyan Gong   +6 more
wiley   +1 more source

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide 1 Receptor Agonists. [PDF]

Diabetes Care
Bea S, Patorno E, Sreedhara SK, Wexler DJ, Cromer SJ, Glynn RJ, Paik JM, Bykov K.   +7 more
europepmc   +1 more source

Oxycodone at the Crossroads of Pain Management, Misuse, and Toxicological Investigation. [PDF]

Metabolites
Ślebioda D, Ślęczka MA, Skowron I, Stanclik M, Mikłuszka M, Chłopaś-Konowałek A.   +5 more
europepmc   +1 more source

The underutilization of oxycodone

Journal of Pain and Symptom Management, 1991
openaire   +2 more sources

Quadratus Lumborum versus Transversus Abdominis Plane Block with Oxycodone or Sufentanil for Recovery Quality After Laparoscopic Gastrointestinal Cancer Surgery: A Factorial Randomized Trial. [PDF]

Drug Des Devel Ther
Yang GW, Song XY, Yang YF, Liu H, Ji FH, Peng K.   +5 more
europepmc   +1 more source

Regarding: "Oxycodone Combined with Dexmedetomidine versus Oxycodone Alone and Sufentanil for Early Postoperative Analgesia and Perioperative Outcomes After Laparoscopic Surgery: A Randomized Controlled Trial" [Letter]. [PDF]

J Pain Res
Luo J, Luo C, Pan W.
europepmc   +1 more source

Complete recovery of thrombotic microangiopathy with severe acute kidney injury due to intravenous use of modified release oxycodone. [PDF]

Clin Kidney J
Ezeakile M, Zirapury T.
europepmc   +1 more source